Table 2:
MRI sequence† | Parameters | Scan time, min:s |
---|---|---|
3-dimensional magnetization-prepared rapid gradient-echo (MPRAGE) |
|
3:45 |
3-dimensional T2-weighted fluid-attenuated inversion recovery (FLAIR) |
|
5:57 |
3-dimensional pseudocontinuous arterial spin labelling (pCASL) |
|
4:27 |
3-dimensional T2-weighted sampling perfection with application-optimized contrasts using different θ evolution (SPACE) |
|
3:42 |
2-dimensional multislice susceptibility-weighted imaging (SWI) |
|
4:02 |
2-dimensional multislice blood-oxygenation-level–dependent (BOLD) resting state functional MRI |
|
9:00 |
2-dimensional multislice 3-shell diffusion-weighted imaging (DWI) |
|
8:34 |
Contrast agent administration | – | |
Dynamic susceptibility contrast (DSC) MRI |
|
3:07 |
Scanning paused |
|
6:53 |
3-dimensional MPRAGE 10 min after injection |
|
3:45 |
Overall | – | 53:12 |
Note: θ = flip angle, FOV = field of view, MRI = magnetic resonance imaging, TE = echo time, TEeff = effective echo time, TI = inversion time, TR = repetition time.
Conducted with the standard head coil.
All sequences are part of the Siemens Healthineers Magnetom Prisma 3 T MRI system with the exception of the pCASL implementation.11